The American Joint Committee on Cancer (AJCC) Breast Cancer Staging, Eighth Edition, is more Reflective of Cancer Biology than the Seventh Edition
Authors:
- 7 February 2025
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 32 (5) , 3268-3277
Abstract
The American Joint Committee on Cancer (AJCC) eighth-edition breast cancer staging system incorporating tumor grade, hormone/human epidermal growth factorKeywords
Funding Information
- National Institutes of Health (R01CA250412, R01CA251545, R01EB029596, R37CA248018)
- U.S. Department of War (W81XWH-19-1-0111, W81XWH-19-1-0674)
This publication has 59 references indexed in Scilit:
- Examining the prevalence of homologous recombination repair defects in ER+ breast cancersBreast Cancer Research and Treatment, 2022
- Homologous recombination deficiency in breast cancer: Implications for risk, cancer development, and therapyGenes, Chromosomes and Cancer, 2020
- Prognostic value of the AJCC 8th edition staging system for Japanese patients treated with surgery followed by radiotherapy for breast cancerInternational Journal of Clinical Oncology, 2020
- Validation of the new AJCC eighth edition of the TNM classification for breast cancer with a single-center breast cancer cohortBreast Cancer Research and Treatment, 2018
- Validation Study of the American Joint Committee on Cancer Eighth Edition Prognostic Stage Compared With the Anatomic Stage in Breast CancerJAMA Oncology, 2018
- Immune Checkpoint Blockade for Breast Cancer2018
- Profiling Tumor Infiltrating Immune Cells with CIBERSORT2018
- Elevated T cell activation score is associated with improved survival of breast cancerBreast Cancer Research and Treatment, 2017
- Using a latent class model to refine risk stratification in multiple myelomaStatistics in Medicine, 2015
- American Joint Committee on Cancer Prognostic Factors Consensus ConferenceCancer, 1999